Jobs / United States / Astrazeneca Pharmaceuticals Lp
Director, CVRM Communications
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Boston - MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles4 certified filings for “Associate Director, Precision Medicine” (Medical Scientists, Except Epidemiologists) in MA: $179k–$260k, median $215k. Most were filed at wage level II (75%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Director, CVRM Communications (Obesity) Boston, MA Global Corporate Affairs Hybrid Work- on average 3 days a week from office This Director, Communications role will be key in developing and executing innovative global communications strategies to support the AstraZeneca’s portfolio in Cardiovascular, Renal and Metabolism (CVRM), with a focus on obesity / weight management and metabolism, as the assets and combinations progress through development. The Communications Director will be a key partner for the cross-functional global franchise teams and global product teams responsible for the clinical development and commercialization of obesity / weight management portfolio, working closely with policy functional leads, key markets and a broad mix of internal stakeholders across BioPharmaceuticals R&D and BBU, CVRM TA, Global Corporate Affairs, Global Medical Affairs, Investor Relations. The role will report to the Head, BioPharma R&D Corporate Affairs with a dotted line into the Head of Global Corporate Affairs, CVRM. AstraZeneca’s weight management and metabolic portfolio is an important growth driver for the Company. Our ambition is to deliver a portfolio of simple, scalable, and sustainable solutions that improve health and wellbeing, reduce cardiometabolic risk, and protect organs in people living with weight-related diseases. AstraZeneca has a strong heritage and experience in CVRM disease. We have one of the broadest and deepest pipelines in the industry. This uniquely positions us to improve outcomes for people affected by obesity, overweight, and diabetes in the future. We are developing oral and injectable therapies, using different modalities and novel mechanisms to expand access and tailor treatment strategies. Obesity and weight-related diseases are an emerging and priority area for AstraZeneca, where there is growing scientific interest and opportunities to transform outcome for those living with disease. It is an area where AstraZeneca has ambitions to be a leading company by delivering the next wave of life-changing medicines. What you'll do • Develop and deliver global communications plans from Phase I through launch with consideration of the full franchise opportunity, including milestones, data readouts, regulatory events, congress presence, partnerships and competitive responses. • Build compelling disease and asset narratives with clear messages and proof points; produce press releases, Q&As and materials for global and local use; prepare and train spokespeople. • Collaborate with global/regional media and country teams; support investor communications with Investor Relations; engage external experts and investigators. • Lead deployment across corporate digital/social channels, leveraging paid and organic opportunities. • Drive internal understanding and engagement for obesity/weight programs; partner with leaders and Global Internal Communications. • Build relationships and co-create programs with patient groups to inform strategy and drive shared agendas in coordinate with the Director of Advocacy, CVRM • Lead issues preparedness and crisis management, including scenario planning, training, tracking and alignment across markets. • Optimize agencies and resources; set objectives and KPIs; ensure strong project management and measurement. Essential for the role • Bachelor's degree • At least 8 years of communications experience primarily in pharmaceutical product communications • Significant pharmaceutical product and healthcare communications experience (in-house or agency) for the global biopharma industry; strong media relations, issues management and patient advocacy experience. • Deep understanding of product and/or pipeline communications, and the communications and campaign required for